This website is intended for healthcare professionals only.

Hospital Healthcare Europe
Hospital Pharmacy Europe     Newsletter       

Clinical

18
Sutimlimab approved in Europe for cold agglutinin haemolytic anaemia
Sutimlimab approved in Europe for cold agglutinin haemolytic anaemia
Read more
Longer rivaroxaban course reduces risk of recurrent venous thromboembolism
Longer rivaroxaban course reduces risk of recurrent venous thromboembolism
Read more
Myocarditis rate higher in younger people following mRNA vaccination
Myocarditis rate higher in younger people following mRNA vaccination
Read more
Telmisartan fails to improve disease severity among patients hospitalised with COVID-19
Telmisartan fails to improve disease severity among patients hospitalised with COVID-19
Read more
Higher olive oil intake linked to lower CVD and all-cause mortality risk
Higher olive oil intake linked to lower CVD and all-cause mortality risk
Read more
Review finds honey improves cardiometabolic risk factors
Review finds honey improves cardiometabolic risk factors
Read more
HDL cholesterol protective role questioned
HDL cholesterol protective role questioned
Read more
Fentanyl vaccine shows promise in animal studies
Fentanyl vaccine shows promise in animal studies
Read more
Dupixent recommended for EU approval to treat moderate to severe prurigo nodularis
Dupixent recommended for EU approval to treat moderate to severe prurigo nodularis
Read more
Multiple sclerosis risk from anti-diabetic medication age dependent
Multiple sclerosis risk from anti-diabetic medication age dependent
Read more
Long-term radiotherapy reduces local breast cancer recurrence but not overall survival
Long-term radiotherapy reduces local breast cancer recurrence but not overall survival
Read more
Trastuzumab deruxtecan treatment of advanced gastric cancer recommended for EU approval 
Trastuzumab deruxtecan treatment of advanced gastric cancer recommended for EU approval 
Read more
Anticoagulation reversal agents equally effective and safe after intracranial haemorrhage
Anticoagulation reversal agents equally effective and safe after intracranial haemorrhage
Read more
Pembrolizumab with radiotherapy equal to cetuximab for advanced head and neck SCC
Pembrolizumab with radiotherapy equal to cetuximab for advanced head and neck SCC
Read more
Digital tumour infiltrating lymphocyte scoring predicts ICI benefit in lung cancer
Digital tumour infiltrating lymphocyte scoring predicts ICI benefit in lung cancer
Read more
Baxdrostat effective in treatment-resistant hypertension
Baxdrostat effective in treatment-resistant hypertension
Read more
Post-COVID-19 condition persists for at least 2 years
Post-COVID-19 condition persists for at least 2 years
Read more
Gantenerumab fails to meet primary outcome in Alzheimer’s disease
Gantenerumab fails to meet primary outcome in Alzheimer’s disease
Read more

Popular articles

Genomic data and technology set to power NHS 10-year plan
New NHS operating model and financial incentives explained
Cardiology, respiratory and dermatology to be prioritised in NHS technology expansion
Can plastic waste really be turned into sustainable paracetamol?
Personalised care plans for majority of complex patients within two years, says Government



 
FOLLOW US

IMPORTANT LINKS

MORE FROM COGORA

© Cogora 2025
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora
x